Annual Total Liabilities
$1.76 M
-$1.38 M-43.98%
December 31, 2023
Summary
- As of February 7, 2025, MNPR annual total liabilities is $1.76 million, with the most recent change of -$1.38 million (-43.98%) on December 31, 2023.
- During the last 3 years, MNPR annual total liabilities has risen by +$580.70 thousand (+49.35%).
- MNPR annual total liabilities is now -43.98% below its all-time high of $3.14 million, reached on December 31, 2022.
Performance
MNPR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.12 M
+$33.40 K+3.07%
September 30, 2024
Summary
- As of February 7, 2025, MNPR quarterly total liabilities is $1.12 million, with the most recent change of +$33.40 thousand (+3.07%) on September 30, 2024.
- Over the past year, MNPR quarterly total liabilities has dropped by -$312.30 thousand (-21.76%).
- MNPR quarterly total liabilities is now -64.21% below its all-time high of $3.14 million, reached on December 31, 2022.
Performance
MNPR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MNPR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.0% | -21.8% |
| 3 y3 years | +49.4% | -9.4% |
| 5 y5 years | +339.8% | +39.3% |
MNPR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.0% | +11.2% | -64.2% | +3.1% |
| 5 y | 5-year | -44.0% | +142.7% | -64.2% | +153.2% |
| alltime | all time | -44.0% | +2624.7% | -64.2% | +286.4% |
Monopar Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.12 M(+3.1%) |
| Jun 2024 | - | $1.09 M(-24.1%) |
| Mar 2024 | - | $1.44 M(-18.3%) |
| Dec 2023 | $1.76 M(-44.0%) | $1.76 M(-11.3%) |
| Sep 2023 | - | $1.98 M(-20.8%) |
| Jun 2023 | - | $2.50 M(-13.4%) |
| Mar 2023 | - | $2.89 M(-8.0%) |
| Dec 2022 | $3.14 M(+98.5%) | $3.14 M(+62.1%) |
| Sep 2022 | - | $1.94 M(-12.8%) |
| Jun 2022 | - | $2.22 M(+101.9%) |
| Mar 2022 | - | $1.10 M(-30.4%) |
| Dec 2021 | $1.58 M | $1.58 M(+27.5%) |
| Sep 2021 | - | $1.24 M(+12.4%) |
| Jun 2021 | - | $1.10 M(+36.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $806.30 K(-31.5%) |
| Dec 2020 | $1.18 M(+62.5%) | $1.18 M(+77.1%) |
| Sep 2020 | - | $664.50 K(+2.5%) |
| Jun 2020 | - | $648.10 K(+46.1%) |
| Mar 2020 | - | $443.50 K(-38.8%) |
| Dec 2019 | $724.20 K(+81.2%) | $724.20 K(+49.7%) |
| Sep 2019 | - | $483.70 K(+3.3%) |
| Jun 2019 | - | $468.30 K(-19.3%) |
| Mar 2019 | - | $580.00 K(+45.1%) |
| Dec 2018 | $399.60 K(+28.1%) | $399.60 K(+28.1%) |
| Sep 2018 | - | $311.90 K(-3.5%) |
| Jun 2018 | - | $323.10 K(+11.2%) |
| Mar 2018 | - | $290.60 K(-6.8%) |
| Dec 2017 | $311.90 K(+383.6%) | $311.90 K |
| Dec 2016 | $64.50 K | - |
FAQ
- What is Monopar Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Monopar Therapeutics?
- What is Monopar Therapeutics annual total liabilities year-on-year change?
- What is Monopar Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Monopar Therapeutics?
- What is Monopar Therapeutics quarterly total liabilities year-on-year change?
What is Monopar Therapeutics annual total liabilities?
The current annual total liabilities of MNPR is $1.76 M
What is the all time high annual total liabilities for Monopar Therapeutics?
Monopar Therapeutics all-time high annual total liabilities is $3.14 M
What is Monopar Therapeutics annual total liabilities year-on-year change?
Over the past year, MNPR annual total liabilities has changed by -$1.38 M (-43.98%)
What is Monopar Therapeutics quarterly total liabilities?
The current quarterly total liabilities of MNPR is $1.12 M
What is the all time high quarterly total liabilities for Monopar Therapeutics?
Monopar Therapeutics all-time high quarterly total liabilities is $3.14 M
What is Monopar Therapeutics quarterly total liabilities year-on-year change?
Over the past year, MNPR quarterly total liabilities has changed by -$312.30 K (-21.76%)